YRYasaman Rezaie

Yasaman Rezaie

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yasaman Rezaie has a total of 23 co-authors. Here are the top co-authors by number of shared publications:

  • Alireza Abdollahi

    Univ Tehran Med Sci, Sch Med, Dept Pathol, Tehran, Iran

    2 shared publications
  • Ahmad Reza Dehpour

    Experimental Medicine Research Center, Tehran University of Medical Sciences

    1 shared publication
  • Aleksandra Barac

    Emerging Infections Subcommittee, European Society of Clinical Microbiology and Infectious Diseases, Basel, Switzerland; Clinic for Infectious and Tropical Diseases, University Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia

    1 shared publication
  • Ardavan Mohammad Aghaei

    Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA; Clinical Neuroscience Research Unit, Connecticut Mental Health Center, New Haven, CT, USA

    1 shared publication
  • Ardavan Tajdini

    Otolaryngology Research Center, Tehran University of Medical Sciences, Tehran, Iran

    1 shared publication
  • Armin Aryannejad

    Univ Pittsburgh, Sch Med, Dept Pathol, Div Expt Pathol, Pittsburgh, PA USA

    1 shared publication

Latest Publications

  • Desmopressin enhances random-pattern skin flap survival in rats: Possible role of vasopressin Type-1a and 2 receptors

    by Pourya Farhangi, Meysam Kaveh, Arya Afrooghe, Razieh Mohammad Jafari, Armin Aryannejad, Baharnaz Mashinchi, Yasaman Rezaie, Alireza Abdollahi, Ahmad-Reza Dehpour


  • Inaccuracy of Standard 2D Photography for the Diagnosis of Cephalic Malposition of Lateral Crural Cartilages

    by Shahin Bastaninejad, Ardavan Tajdini, Yasaman Rezaie

    Lateral crural cephalic malposition (LCCM) is a well-known deformity of the nasal tip which contributes to functional disturbances of the external nasal valve. Accurate diagnosis of this deformity helps surgeons plan for better outcomes. A total of 176 candidate patients for primary rhinoplasty underwent standard 2D medical photography of the face. Senior authors analyzed photography results and differentiated the patients with LCCM. In addition, we measured the angle between the dorsal septum and lateral end of the long axis of the alar cartilage in the operation room. Ninety-five patients were diagnosed with LCCM on photography. As much as 31.3% (55) of all the patients had LCCM in intraoperative measurements. The sensitivity and specificity of 2D photography for diagnosing LCCM were 0.7924 and 0.5391, respectively. The main surgical techniques for correction of LCCM were alar repositioning (34.3% in total, 56% in LCCM patients) and lateral crural strut graft (43.8% in total, 69% in LCCM patients). LCCM is overdiagnosed via 2D photography, and this method lacks sensitivity. The overall frequency of LCCM seems to be lower than the previously reported frequency. For optimal results in rhinoplasty, surgeons must focus on the best contouring and function rather than solely correcting angles and rotations.


  • Discrimination in COVID-19 vaccination programs – A possible risk for mental health

    by Mina Ansari, Ardavan Mohammad Aghaei, Yasaman Rezaie, Yasna Rostam-Abadi


  • Top Cited Papers
    Open Access

    Mucormycosis in patients with COVID‐19: A cross‐sectional descriptive multicentre study from Iran

    by Farzad Pakdel, Kazem Ahmadikia, Mohammadreza Salehi, Azin Tabari, Rozita Jafari, Golfam Mehrparvar, Yasaman Rezaie, Shahin Rajaeih, Neda Alijani, Aleksandra Barac, et al.

    Purpose: The aim of the study was to report clinical features, contributing factors and outcome of patients with coronavirus disease 2019 (COVID‐19)‐associated mucormycosis (CAM).Methods: A cross‐sectional descriptive multicentre study was conducted on patients with biopsy‐proven mucormycosis with RT‐PCR‐confirmed COVID‐19 from April to September 2020. Demographics, the time interval between COVID‐19 and mucormycosis, underlying systemic diseases, clinical features, course of disease and outcomes were collected and analysed.Results: Fifteen patients with COVID‐19 and rhino‐orbital mucormycosis were observed. The median age of patients was 52 years (range 14–71), and 66% were male. The median interval time between COVID‐19 disease and diagnosis of mucormycosis was seven (range: 1–37) days. Among all, 13 patients (86%) had diabetes mellitus, while 7 (46.6%) previously received intravenous corticosteroid therapy. Five patients (33%) underwent orbital exenteration, while seven (47%) patients died from mucormycosis. Six patients (40%) received combined antifungal therapy and none that received combined antifungal therapy died.Conclusion: Clinicians should be aware that mucormycosis may be complication of COVID‐19 in high‐risk patients. Poor control of diabetes mellitus is an important predisposing factor for CAM. Systematic surveillance for control of diabetes mellitus and educating physician about the early diagnosis of CAM are suggested.